Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) to Ring the NASDAQ Stock Market Closing Bell

Published: Aug 07, 2012

ADVISORY, Aug. 7, 2012 (GLOBE NEWSWIRE) -- What: Sarepta Therapeutics, Inc. [SRPT], a developer of innovative RNA-based therapeutics, will visit the NASDAQ MarketSite in Times Square to celebrate its recent positive 36 week clinical data from its Phase IIb study of eteplirsen for the treatment of Duchenne muscular dystrophy. Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases.

Back to news